Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Meridianins are a family of indole alkaloids derived from Antarctic tunicates with extensive pharmacological activities. A series of meridianin derivatives had been synthesized by drug researchers. This article reviews the extraction and purification methods, biological activities and pharmacological applications, pharmacokinetic characters and chemical synthesis of meridianins and their derivatives. And prospects on discovering new bioactivities of meridianins and optimizing their structure for the improvement of the ADMET properties are provided.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781522 | PMC |
| http://dx.doi.org/10.3390/molecules27248714 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
3-Acetyl Indole in the Synthesis of Natural Bioactive Compounds.
Curr Org Synth
April 2025
Laboratoire Lorrain de Chimie Moléculaire (L.2.C.M.), Université de Lorraine, Metz, 57050, France.
Natural products, with their various sources from plants, marine organisms, and microorganisms, are considered a key source and inspiration for medicines and continue to be so. Indole alkaloids are a class of alkaloids and represent a large subunit of natural products. Indole alkaloids of biological importance are numerous and cover a wide range of pharmaceutical applications, including anticancer, antiviral, antimicrobial, anti-inflammatory, and antioxidant.
View Article and Find Full Text PDFNovel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells.
Molecules
December 2024
Institute of Organic Chemistry and Macromolecular Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, D-40225 Düsseldorf, Germany.
(3-(pyrimidin-4-yl)-7-azaindoles) are synthetic hybrids of the naturally occurring alkaloids and and display a strong cytotoxic potential. We have recently shown that the novel derivative is highly cytotoxic in several lymphoma and leukemia cell lines as well as in primary patient-derived lymphoma and leukemia cells and predominantly targets cyclin-dependent kinases (CDKs). Here, we efficiently synthesized nine novel 2-aminopyridyl congeners (-), i.
View Article and Find Full Text PDFNovel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs).
Cell Death Discov
June 2024
Institute for Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.
Article Synopsis
- Cancer messes up how cells grow and divide, and a new way to fight it is by using special compounds called meriolins that stop certain proteins (CDKs) from working.
- Scientists tested two new types of these compounds, meriolin 16 and meriolin 36, and found they were really good at killing cancer cells from lymphoma and leukemia patients.
- By blocking key processes in the cells, like stopping the cell cycle and preventing important actions in gene transcription, these meriolin compounds could be powerful new treatments for cancer.
6-Bromoindirubin-3'-oxime derivatives are highly active colistin adjuvants against .
RSC Med Chem
February 2023
Department of Chemistry and Biochemistry, University of Notre Dame Notre Dame Indiana 46556 USA
Multidrug resistant (MDR) bacterial infections have become increasingly common, leading clinicians to rely on last-resort antibiotics such as colistin. However, the utility of colistin is becoming increasingly compromised as a result of increasing polymyxin resistance. Recently we discovered that derivatives of the eukaryotic kinase inhibitor meridianin D abrogate colistin resistance in several Gram-negative species.
View Article and Find Full Text PDFProtecting-Group-Free Synthesis of Meridianin A-G and Derivatives and Its Antibiofilm Evaluation.
J Org Chem
March 2023
School of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, 550014 Guiyang, P. R. China.
Herein, a protecting-group-free protocol was developed to realize a time and step economy diversification of the Meridianin alkaloid. A broad range of substituents are tolerated to deliver the products in moderate to high yields, and the first synthesis of Meridianin B was achieved. The simplicity of this protocol enables the rapid construction of a Meridianin derivative library for antibiofilm evaluation.
View Article and Find Full Text PDF